Search Tag: AstraZeneca

Executive Health Management

Vaccine Rollout: Implications of “Abundance of Caution”

2021 20 Apr

Over the last week the COVID-19 vaccine landscape has once again changed drastically, with the use of J&J’s Janssen suspended in many countries and new players attracting more attention.   You might also like: Shortages of COVID-19 vaccine supplies are being felt globally, not excluding the EU and the UK. Do companies fulfil their obligations... Read more

Executive Health Management

COVID-19 Vaccine AstraZeneca No More

2021 30 Mar

The Anglo-Swedish pharmaceutical company AstraZeneca has changed the name of its COVID-19 vaccine. You might also like: Shortages of COVID-19 vaccine supplies are being felt globally, not excluding the EU and the UK. Do companies fulfil their obligations and where will new manufacturing facilities be created? Learn more The vaccine... Read more

Executive Health Management

What’s Happening with COVID-19 Vaccine Supply?

2021 29 Mar

Shortages of COVID-19 vaccine supplies are being felt globally, not excluding the EU and the UK. Do companies fulfil their obligations and where will new manufacturing facilities be created?   You might also like: Why has AstraZeneca’s COVID-19 vaccine been the centre of attention in Europe over the past few days? Learn more... Read more

Executive Health Management

Perfect Storm for AstraZeneca COVID-19 Vaccine in EU

2021 14 Mar

AstraZeneca’s COVID-19 vaccine has been the centre of attention in Europe over the past few days. Several countries has suspended its administration after reports of a number of thromboembolic events and several deaths. This has been exacerbated by the company’s inability to meet its contractual obligations in the EU on the medicine delivery.... Read more

Executive Health Management

New Vaccine Agreements for COVAX

2021 23 Jan

COVAX, the global initiative to ensure equitable access to COVID-19 vaccines across the world, has announced new agreements for Pfizer/BioNTech and AstraZeneca/Oxford vaccines delivery, about 200 million doses in total.   You might also like: COVID-19 Vaccines: Tracking and Future Distribution   Specifically,... Read more

Executive Health Management

Major Moves with COVID-19 Vaccines

2020 02 Dec

The UK, first in the world, authorises Pfizer COVID-19 vaccine and is looking into fast-tracking AstraZeneca’s. In the meantime, Pfizer and Moderna both file applications for their vaccines’ emergency use in the U.S. and Europe.   You might also like: Coronavirus, Tensegrity and CSR: Year of Living Dangerously   The... Read more

Executive Health Management

Milestone for COVID-19 Vaccine

2020 18 Nov

Pfizer has completed the Phase 3 of its COVID-19 vaccine trial and is ready to seek authorisation for emergency use in the U.S. The vaccine is reported to be 95% effective. Two other vaccine candidates, those of Moderna and the Russian Gamaleya Research Institute, demonstrated 94.5% and 92% efficacy, respectively, but the trials are still... Read more

Executive Health Management

AZ COVID-19 Trial Continues Despite Participant’s Death

2020 23 Oct

This week has seen another COVID-19 vaccine-related incident: a volunteer in the AstraZeneca (AZ) vaccine trial in Brazil has died. Nevertheless, the trial continues as might the previously halted Johnson & Johnson’s (J&J) and the U.S. arm of AZ’s trial.   You might also like: Rushing COVID-19 Vaccine Development: Is It Justified?... Read more

Executive Health Management

Grand Plans for Potential COVID-19 Vaccine Production

2020 08 Jun

UK-based drugmaker AstraZeneca expands its plans with regard to the COVID-19 vaccine, doubling its manufacturing capacity to 2 billion doses and securing deals with a number of partners.   You might also like: EU Supports Clinical Trials During COVID-19   The vaccine, AZD1222 (previously known as ChAdOx1 nCoV-19), was developed... Read more

Executive Health Management

GSK to Name Jonathan Symonds as New CFO

2019 16 Jul

Jonathan Symonds CBE, former CFO of AstraZeneca and Novartis has been appointed to chairman at GlaxoSmithKline in the wake of the pharmaceutical company’s break-up. Symonds is currently overseeing operations at HSBC, and will replace Sir Philip Hampton, non-executive chairman at GlaxoSmithKline for the past four years. Symonds has previously... Read more